Chemistry:TCS-OX2-29
From HandWiki
Short description: Orexin antagonist
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| Chemical and physical data | |
| Formula | C23H31N3O3 |
| Molar mass | 397.519 g·mol−1 |
| 3D model (JSmol) | |
| |
| (verify) | |
TCS-OX2-29 is an orexin antagonist. It was the first non-peptide antagonist developed that is selective for the orexin receptor subtype OX2, with an IC50 of 40nM and selectivity of around 250x for OX2 over OX1 receptors.[1] Orexin antagonists are expected to be useful for the treatment of insomnia, with subtype-selective antagonists such as TCS-OX2-29 potentially offering more specificity of action compared to non-selective orexin antagonists like almorexant.[2]
References
- ↑ "N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist". Bioorganic & Medicinal Chemistry Letters 13 (24): 4497–9. December 2003. doi:10.1016/j.bmcl.2003.08.038. PMID 14643355.
- ↑ "Orexin receptor antagonists: medicinal chemistry and therapeutic potential". Current Topics in Medicinal Chemistry 8 (11): 977–87. 2008. doi:10.2174/156802608784936746. PMID 18673167.
 |  |
